Labcorp and Rush University System for Health enter into a partnership focused on laboratory, clinical trial and data service

Labcorp now serves as the primary lab for the RUSH network as it embarks on a comprehensive clinical trials relationship Labcorp (NYSE: LH) has entered into a comprehensive partnership with Rush University System for Health (RUSH) to serve as the primary lab for Chicago-based hospitals and physicians in the RUSH network. RUSH will also operate as a site partner for clinical trials through Labcorp’s drug development business, Covance. Together, Labcorp’s diagnostics and drug development expertise, along with RUSH’s deep roots in integrated, academic medicine, will enable scientific innovations and new care options for the communities RUSH serves.